Clinical Trial Update: Safety and Efficacy of Topical NVC-422 Gel in Impetigo [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of topical NVC-422 gel for impetigo has completed enrollment and reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impetigo

Drugs mentioned

• NVC-422 Gel (NVC-422)

Snippet

Sponsor: NovaBay Pharmaceuticals, Inc. | Conditions: Impetigo | Phase 2 | Status: COMPLETED